| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Renal Unit (M.W., M.S., R.T.) and the Department of Obstetrics and Gynecology (J.L.E., R.T.), Massachusetts General Hospital, Boston, Massachusetts 02114; Endocrinology, Diabetes, and Hypertension Division (E.W.S.), Brigham and Women’s Hospital, Boston, Massachusetts 02115; Renal Division (C.L., V.P.S., S.A.K.), Beth Israel-Deaconess Medical Center, Boston, Massachusetts 02215; Magee-Womens Research Institute and Department of Obstetrics and Gynecology and Reproductive Sciences (C.A.H., R.B.N., A.R., A.D., A.S.M.S., J.M.R.), University of Pittsburgh, Pittsburgh, Pennsylvania 15213; and Department of Epidemiology (R.B.N., J.M.R.), University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania 15261
Address all correspondence and requests for reprints to: Ravi Thadhani, M.D., M.P.H., Bulfinch 127, 55 Fruit Street, Massachusetts General Hospital, Boston, Massachusetts 02114. E-mail: rthadhani{at}partners.org.
Altered angiogenesis and insulin resistance are associated with preeclampsia and cardiovascular disease (CVD), and women with preeclampsia appear to be at increased risk of future CVD. We hypothesized that these factors are detectable in asymptomatic postpartum women with a history of preeclampsia and may represent pathophysiological mechanisms bridging preeclampsia and future CVD. We measured fasting insulin, glucose, vascular endothelial growth factor, and its circulating inhibitor, soluble fms-like tyrosine kinase (sFlt-1) in 29 normotensive women with a history of preeclampsia and 32 women with prior normotensive pregnancies at 18.0 ± 9.7 months postpartum. The homeostasis model of insulin resistance (HOMAIR) [(insulin [microunits per milliliter] x glucose [millimoles per liter])/22.5] was calculated. Compared with women with normal pregnancies, women with prior preeclampsia had significantly increased levels of sFlt-1 (41.6 ± 6.7 vs. 30.4 ± 10.2; P < 0.01) and median HOMAIR (2.8 vs. 1.9; P = 0.04). Membership in the upper quartile of either sFlt-1 or HOMAIR was associated with prior preeclampsia (odds ratio 5.7; 95% confidence interval 1.7, 20.0; P < 0.01), and all five women in the upper quartiles of both sFlt-1 and HOMAIR had a history of preeclampsia. Women with a history of preeclampsia demonstrate altered expression of angiogenesis-related proteins and increased HOMAIR more than 1 yr postpartum. These factors may contribute to their risk of future CVD.
This article has been cited by other articles:
 |
|
 |
|
  S. A. Hale, A. Schonberg, G. J. Badger, and I. M. Bernstein Relationship Between Prepregnancy and Early Pregnancy Uterine Blood Flow and Resistance Index Reproductive Sciences, November 1, 2009; 16(11): 1091 - 1096. [Abstract] [PDF]
|
|
|
|
|
|
Tie Weiwei, Yu Haiyan, Chen Juan, Wang Xiaodong, Chen Weibo, and Zhou Rong Expressions of Adiponectin Receptors in Placenta and Their Correlation With Preeclampsia Reproductive Sciences, July 1, 2009; 16(7): 676 - 684. [Abstract] [PDF]
|
|
|
|
 |
|
 K. H. Lampinen, M. Ronnback, P.-H. Groop, and R. J. Kaaja A Relationship Between Insulin Sensitivity and Vasodilation in Women With a History of Preeclamptic Pregnancy Hypertension, August 1, 2008; 52(2): 394 - 401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hubel, R. W. Powers, S. Snaedal, H. S. Gammill, R. B. Ness, J. M. Roberts, and R. Arngrimsson C-Reactive Protein Is Elevated 30 Years After Eclamptic Pregnancy Hypertension, June 1, 2008; 51(6): 1499 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. O. Powrie A 30-Year-Old Woman With Chronic Hypertension Trying to Conceive JAMA, October 3, 2007; 298(13): 1548 - 1558. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Klemmensen, S. F. Olsen, M. L. Osterdal, and A. Tabor Validity of Preeclampsia-related Diagnoses Recorded in a National Hospital Registry and in a Postpartum Interview of the Women Am. J. Epidemiol., July 15, 2007; 166(2): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Lockwood, P. Toti, F. Arcuri, E. Norwitz, E. F. Funai, S.-T. J. Huang, L. F. Buchwalder, G. Krikun, and F. Schatz Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua: Implications for Preeclampsia Am. J. Pathol., April 1, 2007; 170(4): 1398 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Hubel, G. Wallukat, M. Wolf, F. Herse, A. Rajakumar, J. M. Roberts, N. Markovic, R. Thadhani, F. C. Luft, and R. Dechend Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia Hypertension, March 1, 2007; 49(3): 612 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Paradisi, A. Biaggi, R. Savone, F. Ianniello, C. Tomei, L. Caforio, and A. Caruso Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1233 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Vasarhelyi, A. Cseh, I. Kocsis, A. Treszl, B. Gyorffy, and J. Rigo Jr Three mechanisms in the pathogenesis of pre-eclampsia suggested by over-represented transcription factor-binding sites detected with comparative promoter analysis Mol. Hum. Reprod., January 1, 2006; 12(1): 31 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Shibata, A. Rajakumar, R. W. Powers, R. W. Larkin, C. Gilmour, L. M. Bodnar, W. R. Crombleholme, R. B. Ness, J. M. Roberts, and C. A. Hubel Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4895 - 4903. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
